Hui Sheng Biotechnology Co., Ltd.
回盛生物
300871
Shenzhen Stock Exchange
Key Financials
Announcements
Announcement on the Shenzhen Stock Exchange's Decision to Terminate Review of Company's Stock Issuance Application
Announcement on the Completion of Registration Capital and Business Scope Change Registration and Reissuance of Business License
Legal Opinion Letter from Guohao Law Firm (Shenzhen) Regarding the 2025 Annual Shareholders' Meeting of Wuhan Huisheng Biotechnology Co., Ltd.
Announcement of Resolutions from the 2025 Annual Shareholders' Meeting
Announcement of Resolutions of the Seventh Meeting of the Fourth Board of Directors
2026 First Quarter Report
Announcement on the expiration of the plan to issue A-shares to specific objects for the year 2024
Legal Opinion from Guohao Law Firm (Shenzhen) on the Second Extraordinary General Meeting of Shareholders of Wuhan Huisheng Biotechnology Co., Ltd. in 2026
Announcement of Resolutions from the Second Extraordinary General Meeting of Shareholders in 2026
Announcement on the Reappointment of the Audit Institution for the Year 2026
Announcement on Confirming the Remuneration for Directors and Senior Management for the Year 2025 and the Remuneration Plan for 2026
Board of Directors Work Report for the Year 2025
Independent Director's Work Report for the Year 2025 (Cai Xuepeng, Resigned)
Independent Director's Work Report for the Year 2025 (Wang Ming)
Independent Director's Work Report for the Year 2025 (Ran Mingdong)
Announcement on Holding the Online Performance Briefing for the Year 2025
Internal Control Audit Report for the Year 2025
Internal Control Evaluation Report for Wuhan Huisheng Biotechnology Co., Ltd. for the Year 2025
Remuneration Management Measures for Directors and Senior Management (April 2026)
Announcement on Increasing the Guarantee Limit for Wholly-owned Subsidiaries
Notice of the Annual Shareholders' Meeting for the Year 2025
Announcement of Resolutions from the Sixth Meeting of the Fourth Board of Directors
Announcement on the Profit Distribution Plan for 2025 and the Mid-term Dividend Plan for 2026
Special Report from the Board of Directors on the Storage, Management, and Use of Funds Raised for the Year 2025
Verification Report on the Annual Storage, Management, and Use of Funds Raised by Wuhan Huisheng Biotechnology Co., Ltd.
CITIC Construction Investment Securities Co., Ltd. Special Verification Report on the Storage, Management, and Use of Funds Raised by Wuhan Huisheng Biotechnology Co., Ltd. for the Year 2025
Evaluation Report on the Performance of the Accounting Firm for the Year 2025
Report of the Audit Committee on the Performance of Supervisory Duties by the Accounting Firm
Special Audit Report on the Summary Table of Non-Operating Fund Occupation and Other Related Fund Transactions by Wuhan Huisheng Biotechnology Co., Ltd.
Summary Table of Non-Operating Fund Occupation and Other Related Fund Transactions for the Year 2025 by Wuhan Huisheng Biotechnology Co., Ltd.
Special Opinion of the Board on the Independence of Independent Directors
2025 Annual Audit Report
2025 Annual Report
Summary of the 2025 Annual Report
Announcement on Extending the Validity Period of the Shareholders' Meeting Resolution for the Company's 2024 A-share Issuance to Specific Objects and Related Authorizations
Progress Announcement on Providing Guarantees for Subsidiaries
Notice of the 2026 Second Extraordinary Shareholders' Meeting
Resolution Announcement of the 5th Meeting of the 4th Board of Directors
Announcement on the Completion of Cancellation of Repurchased Shares and Share Changes
Progress Announcement on Providing Guarantees for Subsidiaries
Resolution announcement of the first meeting of all holders of the 2026 employee stock ownership plan
Announcement on the completion of non-transactional transfer of the 2026 employee stock ownership plan
Announcement on Cancelling Part of Repurchased Shares to Reduce Registered Capital and Notifying Creditors
Articles of Association (Revised in February 2026)
Grandall Law Firm (Shenzhen) Legal Opinion on Wuhan Huishang Biotechnology Co., Ltd.'s First Extraordinary General Meeting in 2026
Resolution Announcement of the First Extraordinary General Meeting in 2026
Announcement on Receiving Government Subsidies
Notes & Comments
Sign in to leave a comment or private note.
Loading…